SLC25A20 and central nervous system cancer: We show that mRNA expression of the prototypical MCT, SLC16A1 (MCT1), for instance, is higher in gliomas compared with corresponding normal brain tissue but otherwise non-discriminatory, while that of SLC25A20 is more emphasised in HGG (Supplementary Fig. S6).